bromopyruvate has been researched along with Ovarian Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bartosz, G; Furdak, P; Pieńkowska, N; Sadowska-Bartosz, I | 1 |
| Amiji, MM; Gandham, SK; Singh, A; Talekar, M | 1 |
| Fuxe, J; Johansson, J; Löfstedt, L; Pedersen, AB; Shoshan, M; Wintzell, M | 1 |
3 other study(ies) available for bromopyruvate and Ovarian Neoplasms
| Article | Year |
|---|---|
Delphinidin Increases the Sensitivity of Ovarian Cancer Cell Lines to 3-Bromopyruvate.
Topics: Adenosine Triphosphate; Anthocyanins; Antineoplastic Agents; Cell Line; Cell Line, Tumor; Cell Movement; Cell Survival; Drug Synergism; Ethidium; Female; Fibroblasts; Flavonoids; Glutathione; Humans; Membrane Potential, Mitochondrial; Mitochondria; Ovarian Neoplasms; Pyruvates; Reactive Oxygen Species | 2021 |
Inhibition of hexokinase-2 with targeted liposomal 3-bromopyruvate in an ovarian tumor spheroid model of aerobic glycolysis.
Topics: Aerobiosis; Cell Line, Tumor; Female; Glycolysis; Hexokinase; Humans; Liposomes; Ovarian Neoplasms; Pyruvates; Spheroids, Cellular; Tumor Cells, Cultured | 2015 |
Repeated cisplatin treatment can lead to a multiresistant tumor cell population with stem cell features and sensitivity to 3-bromopyruvate.
Topics: Aldehyde Dehydrogenase 1 Family; Antineoplastic Agents; Ascites; Biomarkers, Tumor; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Humans; Hyaluronan Receptors; Isoenzymes; Neoplasms, Glandular and Epithelial; Neoplastic Stem Cells; Ovarian Neoplasms; Proto-Oncogene Proteins c-kit; Pyruvates; Retinal Dehydrogenase | 2012 |